Health Care Archives - Spark Newswire

1 minute read

Competition and Optimism: GSK’s CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market

Yesterday, 2:15 PM

Emma Walmsley, the Chief Executive Officer of GSK plc (NYSE: GSK), expressed confidence in its respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales to surpass £1 billio

GSK

1 minute read

Why Is This Rare Disease-Focused Soligenix Stock Trading Over 200% Today?

By Vandana Singh

Yesterday, 12:07 PM

The FDA has cleared Soligenix Inc's (NASDAQ: SNGX) Investigational New Drug (IND) application for a Phase 2a clinical trial for SGX945 (dusquetide) for aphthous

SNGX

1 minute read

ImmunoGen’s Flagship Cancer Therapy Draws AbbVie’s Attention With $10.1B Deal

By Vandana Singh

Yesterday, 11:30 AM

AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved f

ABBV

2 minute read

Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient

By Vandana Singh

Yesterday, 11:09 AM

Novo Nordisk A/S (NYSE: NVO) has reportedly taken legal action against Florida compounding pharmacies, suing one and refiling a lawsuit against another, as it discovered impurities in their products claiming to contain the active ingredient, semaglutide, for its popular

LLY

1 minute read

Why Is Eagle Pharmaceuticals Stock Trading Lower Today?

By Vandana Singh

November 29, 2:46 PM

Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Scott Tarriff, founder, president, and Chief Executive Officer, announced his resignation and retirement,

EGRX

2 minute read

Cathie Wood’s ARK Innovation ETF Achieves 35% Gain In November, Its Best Month Since Inception

By Piero Cingari

November 29, 2:32 PM

The ARK Innovation ETF (NYSE:ARKK), managed by renowned investor Cathie Wood, has posted remarkable gains in November, making it the fund’s best-performing month since its launch in 2014.

ARKF

1 minute read

AbbVie’s Lung Cancer Study Shows Encouraging Clinical Benefits In Subtype Of Patients

By Vandana Singh

November 29, 2:21 PM

AbbVie Inc (NYSE: ABBV) announced topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type,

ABBV

2 minute read

What’s Going On With Healthcare Insurance Giant Cigna Stock Today?

By Vandana Singh

November 29, 2:02 PM

Cigna Group (NYSE: CI) and Humana Inc (NYSE: HUM) are reportedly discussing a merger deal to create a new powerhouse in the health insurance industry.

1 minute read

Why Is Bacterial Infection-Focused BiomX Stock Trading Lower Today?

By Vandana Singh

November 29, 1:00 PM

BiomX Inc (NYSE: PHGE) released safety and efficacy results from Part 2 of the Phase 1b/2a trial of BX004 for chronic pulmonary infections caused by Pseudomonas aeruginosa (P.

PHGE

1 minute read

Why Is Alzheimer’s-Focused BioVie Stock Trading Lower Today?

By Vandana Singh

November 29, 12:29 PM

BioVie Inc (NASDAQ: BIVI) shares are trading lower after the company released an analysis of unblinded, topline efficacy data from its Phase 3 trial of NE3107 for mild to

BIVI